Koru Medical Systems (NSDQ:KRMD) shares ticked up today on fourth-quarter results that topped the consensus forecast.
The Chester, New York-based infusion technology developer posted losses of $1.1 million, or 2¢ per share, on sales of $6.5 million for the three months ended Dec. 31, 2021, for a bottom-line slide further into the red on sales growth of 60%.
Adjusted to exclude one-time items, losses per share were also 2¢ Wall Street, where analysts were looking for sales of $6.1 million.
Get the full story at our sister site, Drug Delivery Business News.